This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Abrams, P. J. Search for Related Content Social Bookmarking                         What's this?

Pharmacologic Treatments for Pain Associated With Diabetic Peripheral Neuropathies

260 Faller Dr. Apt. C., New Milford, NJ 07646, paris.abrams @gmail.com

Diabetic peripheral neuropathy (DPN) is a complication of diabetes mellitus that occurs in both type 1 and type 2 diabetics. This complication is estimated to be prevalent in approximately 50% of the diabetic population and is associated with significant morbidity and mortality. Painful DPNs affect a minority of patients with DPN but are often chronic, severe, and debilitating. Many pharmacologic agents—including but not limited to pregabalin, duloxetine, tricyclic antidepressants, abapentin, and carbamazepine—have been studied and proven effective for the treatment of pain associated with DPN. Data from these studies were extracted and evaluated to compile a list of agents that are effective in treating painful diabetic neuropathies.

Key Words: Diabetic neuropathies • peripheral neuropathies • tricyclic antidepressants • anticonvulsants • pregabalin • duloxetine.

Journal of Pharmacy Practice, Vol. 20, No. 1, 103-109 (2007)
DOI: 10.1177/0897190007304831


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?